Abstract
Background: Monoclonal antibodies are nowadays by far the most important of all biotherapeutics. Unfortunately, they are complex proteins, so that their production is complicated and expensive, which eventually leads to an elevated average cost per treatment per patient. An important research effort is dedicated to the development of a process that may allow a reduction of antibodies production costs.
Objective: In particular, the main target is to replace the capture step based on the very expensive use of protein A beads, which is, and has been, the standard for the last 20 years. Among the possible alternatives the use of membrane chromatography for antibody capture will be considered in this work. Despite the development of new convective stationary phases with improved binding capacity, the use of membrane adsorbers for capture chromatography is still limited to niche applications. Conventional packed bead columns are still preferred due to their higher binding capacity even if they suffer from several limitations such as high pressure drop, slow mass transfer through the diffusive pores and strong dependence of the binding capacity on flow rate. An overview of the recent work performed in the field and a critical review of how technology advances could make a breakthrough will be presented here.Keywords: Antibody, affinity, chromatography, immunoglobulin, ion-exchange, membrane adsorbers, purification.
Current Organic Chemistry
Title:Advances in Membrane Chromatography for the Capture Step of Monoclonal Antibodies
Volume: 21 Issue: 17
Author(s): Cristiana Boi*Simone Dimartino
Affiliation:
- Dipartimento di Ingegneria Civile, Chimica, Ambientale e dei Materiali, Università di Bologna, via Terracini 28, 40131 Bologna,Italy
Keywords: Antibody, affinity, chromatography, immunoglobulin, ion-exchange, membrane adsorbers, purification.
Abstract: Background: Monoclonal antibodies are nowadays by far the most important of all biotherapeutics. Unfortunately, they are complex proteins, so that their production is complicated and expensive, which eventually leads to an elevated average cost per treatment per patient. An important research effort is dedicated to the development of a process that may allow a reduction of antibodies production costs.
Objective: In particular, the main target is to replace the capture step based on the very expensive use of protein A beads, which is, and has been, the standard for the last 20 years. Among the possible alternatives the use of membrane chromatography for antibody capture will be considered in this work. Despite the development of new convective stationary phases with improved binding capacity, the use of membrane adsorbers for capture chromatography is still limited to niche applications. Conventional packed bead columns are still preferred due to their higher binding capacity even if they suffer from several limitations such as high pressure drop, slow mass transfer through the diffusive pores and strong dependence of the binding capacity on flow rate. An overview of the recent work performed in the field and a critical review of how technology advances could make a breakthrough will be presented here.Export Options
About this article
Cite this article as:
Boi Cristiana*, Dimartino Simone, Advances in Membrane Chromatography for the Capture Step of Monoclonal Antibodies, Current Organic Chemistry 2017; 21 (17) . https://dx.doi.org/10.2174/1385272820666160610114814
DOI https://dx.doi.org/10.2174/1385272820666160610114814 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Long-Term Multimodal Therapy (Verapamil Associated with Propolis, Blueberry, Vitamin E and Local Diclofenac) on Patients with Peyronie's Disease (Chronic Inflammation of the Tunica Albuginea). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
Current Gene Therapy Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer
Current Drug Targets Pro-inflammatory Cytokines Modulate Glial Apolipoprotein E Secretion
Current Alzheimer Research Rational Design of Novel Potential p38α MAPK Inhibitors with Drug-like Properties Using Pharmacophore and Similarity-based Virtual Screening Procedures
Current Bioactive Compounds Mesenchymal Stem Cells Derived from Wharton's Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications
Current Stem Cell Research & Therapy Neuronal Nitric Oxide Synthase and Sympathetic Nerve Activity in Neurovascular and Metabolic Systems
Current Neurovascular Research Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design CD93 and Related Family Members: Their Role in Innate Immunity
Current Drug Targets Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°
Current Medicinal Chemistry - Anti-Infective Agents Triamcinolone as a Potential Inhibitor of SARS-CoV-2 Main Protease and Cytokine Storm: An <i>In silico</i> Study
Letters in Drug Design & Discovery Preface [Hot Topic: Therapeutic Manipulation of the Immune System: Old and New Therapeutic Approaches (Executive Editor : Emilio Jirillo)]
Current Pharmaceutical Design Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action
Current Medicinal Chemistry Clinical Pharmacology of Ibuprofen and Indomethacin in Preterm Infants with Patent Ductus Arteriosus
Current Pediatric Reviews Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases
Current Medicinal Chemistry The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry